Angioimmunoblastic T-cell lymphoma medical therapy
From Wikidoc - Reading time: 1 min
|
Angioimmunoblastic T-cell lymphoma Microchapters |
|
Differentiating Angioimmunoblastic T-cell lymphoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Angioimmunoblastic T-cell lymphoma medical therapy On the Web |
|
American Roentgen Ray Society Images of Angioimmunoblastic T-cell lymphoma medical therapy |
|
Angioimmunoblastic T-cell lymphoma medical therapy in the news |
|
Directions to Hospitals Treating Angioimmunoblastic T-cell lymphoma |
|
Risk calculators and risk factors for Angioimmunoblastic T-cell lymphoma medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sowminya Arikapudi, M.B,B.S. [2]
Overview[edit | edit source]
The predominant therapy for angioimmunoblastic T-cell lymphoma is chemotherapy. Adjunctive stem cell transplantation may be required.
Medical Therapy[edit | edit source]
Chemotherapy[1][edit | edit source]
Drug Regimen: (CHOP) Cyclophosphamide AND Doxorubicin AND Vincristine AND Prednisone
Stem cell transplant[1][edit | edit source]
A stem cell transplant may be an option for some people with angioimmunoblastic T-cell lymphoma.
References[edit | edit source]
- ↑ 1.0 1.1 Angioimmunoblastic T-cell lymphoma. Canadian Cancer Society. http://www.cancer.ca/en/cancer-information/cancer-type/non-hodgkin-lymphoma/non-hodgkin-lymphoma/types-of-nhl/angioimmunoblastic-t-cell-lymphoma/?region=nb Accessed on November 16,2015
EncycloReader
is supported by the 
KSF